{
  "guideline": {
    "id": "PA166328709",
    "name": "FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]: Sacituzumab Govitecan-hziy - UGT1A1",
    "objCls": "PGx Association",
    "source": "FDA",
    "version": 0,
    "url": "https://www.pharmgkb.org/fdaPgxAssociations#PA166328709",
    "relatedChemicals": [
      {
        "id": "PA166225061",
        "name": "sacituzumab govitecan",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA420",
        "name": "UDP glucuronosyltransferase 1 family, polypeptide A1",
        "symbol": "UGT1A1"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166317861",
      "name": "Recommendation Annotation PA166317861",
      "population": "Affected subgroup: UGT1A1*28/*28 (poor metabolizers)",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166225061",
          "name": "sacituzumab govitecan",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452269120,
        "html": "<p>&quot;May result in higher systemic concentrations and adverse reaction risk (neutropenia). Monitor for adverse reactions and tolerance to treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "UGT1A1": "Poor Metabolizer"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    }
  ],
  "citations": [],
  "version": "2024-03-08-14-34"
}